Septerna (SEPN) Other Non-Current Assets (2023 - 2026)
Septerna (SEPN) recorded quarterly Other Non-Current Assets of $773000.0 in Q1 2026, down 14.59% quarter-over-quarter from $905000.0 in Q4 2025, and down 14.59% on a YoY basis from $905000.0 in Q1 2025.
Septerna (SEPN) Other Non-Current Assets (2023 - 2026) Analysis & Trends
Septerna's Other Non-Current Assets history runs 4 years deep, the most recent figure standing at $773000.0 for Q1 2026.
- In Q1 2026, Other Non-Current Assets fell 14.59% year-over-year to $773000.0; the TTM figure through Mar 2026 stood at $773000.0 (down 14.59% YoY), while the FY2025 annual figure was $905000.0, up 238.95% from the prior year.
- Other Non-Current Assets was $773000.0 for Q1 2026 at Septerna, down from $905000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $3.5 million in Q3 2024 to a low of $267000.0 in Q4 2024.
- Historically, Other Non-Current Assets has averaged $1.1 million across 4 years, with a median of $905000.0 in 2023.
- The sharpest annual moves came in 2024 and 2025: Other Non-Current Assets soared 284.42% in 2024, then slumped 73.99% in 2025.
- A 4-year view of Other Non-Current Assets shows it stood at $905000.0 in 2023, then plunged by 70.5% to $267000.0 in 2024, then jumped by 238.95% to $905000.0 in 2025, then fell by 14.59% to $773000.0 in 2026.
- The last three Other Non-Current Assets figures came in at $773000.0 (Q1 2026), $905000.0 (Q4 2025), and $905000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 60,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Septerna | 1.62 Bn | 1.62 Bn | - | 773,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 773,000.00 |
| Dec 31, 2025 | 905,000.00 |
| Sep 30, 2025 | 905,000.00 |
| Jun 30, 2025 | 905,000.00 |
| Mar 31, 2025 | 905,000.00 |
| Dec 31, 2024 | 267,000.00 |
| Sep 30, 2024 | 3.48 Mn |
| Jun 30, 2024 | 905,000.00 |
| Mar 31, 2024 | 905,000.00 |
| Dec 31, 2023 | 905,000.00 |
| Sep 30, 2023 | 905,000.00 |